Cost, Data Analysis, and Throughput Keep Some Array Users from Switching to Sequencers | GenomeWeb
NEW YORK (GenomeWeb News) - Some life-sciences tool vendors have pledged that digital gene-expression applications performed on their second-generation sequencing platforms will eventually dominate the gene-expression market at the expense of arrays, but several experts familiar with both technologies say cost, data analysis, and throughput issues are continuing to encourage researchers to choose arrays over DGE.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.